355 related articles for article (PubMed ID: 28262487)
1. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
[TBL] [Abstract][Full Text] [Related]
2. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration.
Di Stefano M; Nascimento-Ferreira I; Orsomando G; Mori V; Gilley J; Brown R; Janeckova L; Vargas ME; Worrell LA; Loreto A; Tickle J; Patrick J; Webster JR; Marangoni M; Carpi FM; Pucciarelli S; Rossi F; Meng W; Sagasti A; Ribchester RR; Magni G; Coleman MP; Conforti L
Cell Death Differ; 2015 May; 22(5):731-42. PubMed ID: 25323584
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
4. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
[TBL] [Abstract][Full Text] [Related]
6. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
Yamagishi Y; Tessier-Lavigne M
Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
[TBL] [Abstract][Full Text] [Related]
7. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.
Milde S; Gilley J; Coleman MP
Bioarchitecture; 2013; 3(5):133-40. PubMed ID: 24284888
[TBL] [Abstract][Full Text] [Related]
8. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.
Lukacs M; Gilley J; Zhu Y; Orsomando G; Angeletti C; Liu J; Yang X; Park J; Hopkin RJ; Coleman MP; Zhai RG; Stottmann RW
Exp Neurol; 2019 Oct; 320():112961. PubMed ID: 31136762
[TBL] [Abstract][Full Text] [Related]
9. Rescue of peripheral and CNS axon defects in mice lacking NMNAT2.
Gilley J; Adalbert R; Yu G; Coleman MP
J Neurosci; 2013 Aug; 33(33):13410-24. PubMed ID: 23946398
[TBL] [Abstract][Full Text] [Related]
10. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
[TBL] [Abstract][Full Text] [Related]
11. Sarm1 Deletion, but Not Wld
Gilley J; Ribchester RR; Coleman MP
Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
[TBL] [Abstract][Full Text] [Related]
12. Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria.
Loreto A; Di Stefano M; Gering M; Conforti L
Cell Rep; 2015 Dec; 13(11):2539-2552. PubMed ID: 26686637
[TBL] [Abstract][Full Text] [Related]
13. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
[TBL] [Abstract][Full Text] [Related]
14. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons.
Gilley J; Coleman MP
PLoS Biol; 2010 Jan; 8(1):e1000300. PubMed ID: 20126265
[TBL] [Abstract][Full Text] [Related]
15. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
16. The NAD
Llobet Rosell A; Paglione M; Gilley J; Kocia M; Perillo G; Gasparrini M; Cialabrini L; Raffaelli N; Angeletti C; Orsomando G; Wu PH; Coleman MP; Loreto A; Neukomm LJ
Elife; 2022 Dec; 11():. PubMed ID: 36476387
[TBL] [Abstract][Full Text] [Related]
17. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.
Milde S; Fox AN; Freeman MR; Coleman MP
Sci Rep; 2013; 3():2567. PubMed ID: 23995269
[TBL] [Abstract][Full Text] [Related]
18. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.
Shen H; Hyrc KL; Goldberg MP
Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229
[TBL] [Abstract][Full Text] [Related]
19. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of initiation and regulation of axonal degeneration with special reference to NMNATs and Sarm1.
Funakoshi M; Araki T
Neurosci Res; 2023 Dec; 197():3-8. PubMed ID: 34767875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
